Nakagawa H, Kobayashi H, Koezuka M, Yamada M, Miyawaki Y, Tokiyoshi K, Kanayama T, Hagiwara Y, Tsuruzono K
Department of Neurosurgery, Center for Adult Diseases, Osaka.
No Shinkei Geka. 1994 Jun;22(6):517-23.
Chemotherapy with CDDP and/or other agents was performed in 15 patients after removal of metastatic brain tumors. A chemosensitivity test using a system of collagen gel-embedded culture and computerized image analysis was performed on the tumors from these patients. The clinical usefulness of the chemosensitivity test was evaluated by comparing chemotherapeutic effects with the results of the test. The rates of correlation of the chemosensitivity test with clinical response on brain MRI was 80%, and that of the chemosensitivity test with clinical response in tumor markers or on primary tumors was 75%. This observation suggests that the chemosensitivity test using collagen gel-embedded culture and computerized image analysis is useful in determining optimal chemotherapy for metastatic brain tumors. In ten multiple metastatic brain tumors, three complete responses, two partial responses, one minor response and four non-responses were observed on MRI. Only one case showed a false negative result on the chemosensitivity test and showed partial response. This result also indicates the effectiveness of chemotherapy based on chemosensitivity testing.
15例转移性脑肿瘤切除术后患者接受了顺铂和/或其他药物的化疗。对这些患者的肿瘤进行了使用胶原凝胶包埋培养系统和计算机图像分析的化疗敏感性测试。通过将化疗效果与测试结果进行比较,评估化疗敏感性测试的临床实用性。化疗敏感性测试与脑MRI临床反应的相关性为80%,与肿瘤标志物或原发肿瘤临床反应的相关性为75%。这一观察结果表明,使用胶原凝胶包埋培养和计算机图像分析的化疗敏感性测试有助于确定转移性脑肿瘤的最佳化疗方案。在10例多发转移性脑肿瘤患者中,MRI显示3例完全缓解、2例部分缓解、1例轻度缓解和4例无反应。只有1例在化疗敏感性测试中出现假阴性结果,但显示部分缓解。这一结果也表明了基于化疗敏感性测试的化疗的有效性。